Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2017 Filed Mar 31, 2017 20:46 UTC |
Katkin KeithDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0001562180-17-001365 · primarydocument.xml · derivative · entry 1 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-03-29 F1 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest monthly over a three-year period. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 13:37 UTC |
ROYSTON IVORDirector
|
Disposition to issuerCommon Stock | 125,000 | $13.75 | $1,718,750.00 |
DisclosureSEC source: 0001562180-17-001301 · primarydocument.xml · nonDerivative · entry 1 ROYSTON IVOR · CIK 0001026765 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 625,545 F1 · ownership.nature: The securities are owned directly by Forward Ventures V, LP ("Forward V"), Forward Ventures IV, LP ("Forward IV") and Forward Ventures IVB, LP ("Forward IVB" and collectively, the "Forward Entities"). Dr. Royston is a member of Forward V and a managing member of Forward IV Associates, LLC which is the general partner of each of Forward IV and Forward IVB. As a result, Dr. Royston shares voting and investment power over the shares owned by the Forward Entities. Dr. Royston disclaims beneficial ownership of all shares held by the Forward Entities, except to the extent of his actual pecuniary interest therein. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 10:32 UTC |
Shea Richard PChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0001562180-17-000692 · primarydocument.xml · derivative · entry 1 Shea Richard P · CIK 0001294354 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-02-13 F1 · derivative.exercise_date: Twenty-five percent (25%) of the total number of shares underlying the option shall vest on February 13, 2018, and one forty-eighth (1/48th) of the total number of shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 19:13 UTC |
Ordentlich PeterChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001562180-17-000570 · primarydocument.xml · derivative · entry 1 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-02-06 F1 · derivative.exercise_date: The stock option will vest in 48 successive equal monthly installments measured from February 6, 2017. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 19:13 UTC |
Morrison BriggsDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001562180-17-000569 · primarydocument.xml · derivative · entry 1 Morrison Briggs · CIK 0001654430 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2027-02-06 F1 · derivative.exercise_date: The stock option will vest in 48 successive equal monthly installments measured from February 6, 2017. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 19:13 UTC |
Meyers Michael L.SVP, Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 66,100 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001562180-17-000568 · primarydocument.xml · derivative · entry 1 Meyers Michael L. · CIK 0001664204 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,100 Underlying: Common Stock · 66,100 shares Expires 2027-02-06 F1 · derivative.exercise_date: The stock option will vest in 48 successive equal monthly installments measured from February 6, 2017. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 19:13 UTC |
Metzger Michael APresident and COO
|
GrantStock Option (Right to Buy) · Derivative | 95,000 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001562180-17-000567 · primarydocument.xml · derivative · entry 1 Metzger Michael A · CIK 0001507220 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2027-02-06 F1 · derivative.exercise_date: The stock option will vest in 48 successive equal monthly installments measured from February 6, 2017. Read SEC document |
| January 04, 2017 Filed Jan 5, 2017 17:05 UTC |
Legault PierreDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.08 | $0.00 |
DisclosureSEC source: 0001562180-17-000193 · primarydocument.xml · derivative · entry 1 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-01-04 F1 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest monthly over a three-year period. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 17:25 UTC |
Chen HenryDirector
|
GrantStock Options (Right to buy) · Derivative | 8,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001562180-16-003358 · primarydocument.xml · derivative · entry 1 Chen Henry · CIK 0001667481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2026-10-31 F1 · derivative.exercise_date: One hundred percent (100%) of the total number of shares underlying the option shall vest on October 31, 2017, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 17:25 UTC |
ROYSTON IVORDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001562180-16-003355 · primarydocument.xml · derivative · entry 1 ROYSTON IVOR · CIK 0001026765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2026-10-31 F1 · derivative.exercise_date: One hundred percent (100%) of the total number of shares underlying the option shall vest on October 31, 2017, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 21:25 UTC |
EVNIN LUKEDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001562180-16-003353 · primarydocument.xml · derivative · entry 1 EVNIN LUKE · CIK 0001134657 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2026-10-31 F1 · derivative.exercise_date: One hundred percent (100%) of the total number of shares underlying the option shall vest on October 31, 2017, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 17:25 UTC |
Podlesak DennisDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001562180-16-003354 · primarydocument.xml · derivative · entry 1 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2026-10-31 F1 · derivative.exercise_date: One hundred percent (100%) of the total number of shares underlying the option shall vest on October 31, 2017, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 17:25 UTC |
Shea Richard PDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001562180-16-003356 · primarydocument.xml · derivative · entry 1 Shea Richard P · CIK 0001294354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2026-10-31 F1 · derivative.exercise_date: One hundred percent (100%) of the total number of shares underlying the option shall vest on October 31, 2017, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 21:25 UTC |
Sledge George W. Jr.Director
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001562180-16-003357 · primarydocument.xml · derivative · entry 1 Sledge George W. Jr. · CIK 0001601351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2026-10-31 F1 · derivative.exercise_date: One hundred percent (100%) of the total number of shares underlying the option shall vest on October 31, 2017, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 21:25 UTC |
Egros FabriceDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0001562180-16-003352 · primarydocument.xml · derivative · entry 1 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2026-10-31 F1 · derivative.exercise_date: One hundred percent (100%) of the total number of shares underlying the option shall vest on October 31, 2017, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 20:44 UTC |
Kamdar Kim P.Director · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $11.81 | $0.00 |
DisclosureSEC source: 0000904454-16-001523 · edgar.xml · derivative · entry 1 Kamdar Kim P. · CIK 0001535065 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2026-10-31 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.